tamoxifen citrate

Generic: tamoxifen citrate

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tamoxifen citrate
Generic Name tamoxifen citrate
Labeler mylan pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tamoxifen citrate 20 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 0378-0274
Product ID 0378-0274_2c1fe025-1eb2-4b2f-b8c9-5d0cfc3c683e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074732
Listing Expiration 2026-12-31
Marketing Start 2003-02-20

Pharmacologic Class

Classes
estrogen agonist/antagonist [epc] selective estrogen receptor modulators [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03780274
Hyphenated Format 0378-0274

Supplemental Identifiers

RxCUI
198240 313195
UNII
7FRV7310N6

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tamoxifen citrate (source: ndc)
Generic Name tamoxifen citrate (source: ndc)
Application Number ANDA074732 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (0378-0274-93)
source: ndc

Packages (1)

0378-0274-93 30 TABLET in 1 BOTTLE (0378-0274-93)

Ingredients (1)

tamoxifen citrate (20 mg/1)

Linked Drug Pages (1)

Tamoxifen Citrate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2c1fe025-1eb2-4b2f-b8c9-5d0cfc3c683e", "openfda": {"unii": ["7FRV7310N6"], "rxcui": ["198240", "313195"], "spl_set_id": ["7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (0378-0274-93)", "package_ndc": "0378-0274-93", "marketing_start_date": "20030220"}], "brand_name": "Tamoxifen Citrate", "product_id": "0378-0274_2c1fe025-1eb2-4b2f-b8c9-5d0cfc3c683e", "dosage_form": "TABLET", "pharm_class": ["Estrogen Agonist/Antagonist [EPC]", "Selective Estrogen Receptor Modulators [MoA]"], "product_ndc": "0378-0274", "generic_name": "Tamoxifen Citrate", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tamoxifen Citrate", "active_ingredients": [{"name": "TAMOXIFEN CITRATE", "strength": "20 mg/1"}], "application_number": "ANDA074732", "marketing_category": "ANDA", "marketing_start_date": "20030220", "listing_expiration_date": "20261231"}